← Back to Patent Explorer
US4022206A Expired / Lapsed US ⏱️ 0.0 years remaining

Vaccine delivery system

Assignee: Merck and Co Inc
•
Filing: 1975-08-01
•
Granted: 1977-05-10
•
Expires: 1995-08-01
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Vaccine delivery system having a lyophilized vaccine in human dosage concentration loaded into presterilized single dosage syringe having a squeezable body portion and a separate package containing enough water for injection to reconstitute the single dose of lyophilized vaccine.

Inventors

  • 👤 Maurice R. Hilleman
  • 👤 William J. McAleer

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 09:07
CPC Classifications
A; A61; A61M; A61M5/00; A61M5/178; A61M5/28; A61M5/281; A61M5/282; A61M5/285; A61M5/288

Claims Analysis

Total Claims: 15
Claim 1
Independent Claim 133 words
A vaccine delivery system suitable for human administration comprising a hypodermic syringe having a single dosage container portion made of a plastic material which is resiliently flexible at room temperature and a needle portion comprising a hollow sharp needle extending from the plastic container portion to convey fluids from within the container out through the tip of the needle when the needle is inserted under the skin and the container is squeezed, a vaccine in an amount suitable for human administration sealed within the container, the vaccine being in the lyophilized state, whereby the vaccine is preserved for storage and shipment and the syringe is protected from leakage during storage and shipment, and a separate container of a single dose of water for injection to reconstitute the lyophilized vaccine in the hypodermic syringe.
Claim 2
Dependent Claim 133 words
A vaccine delivery system suitable for human administration comprising a hypodermic syringe having a single dosage container portion made of a plastic material which is resiliently flexible at room temperature and a needle portion comprising a hollow sharp needle extending from the plastic container portion to convey fluids from within the container out through the tip of the needle when the needle is inserted under the skin and the container is squeezed, a vaccine in an amount suitable for human administration sealed within the container, the vaccine being in the lyophilized state, whereby the vaccine is preserved for storage and shipment and the syringe is protected from leakage during storage and shipment, and a separate container of a single dose of water for injection to reconstitute the lyophilized vaccine in the hypodermic syringe.
Claim 3
Dependent Claim 20 words
A vaccine delivery system according to claim 1 wherein said vaccine is at a temperature of below about 8° C.
Claim 4
Dependent Claim 18 words
A vaccine delivery system according to claim 1 wherein said container portion is composed of low density polyethylene.
Claim 5
Dependent Claim 22 words
A vaccine delivery system according to claim 1 wherein the container for the water for injection is formed of low density polyethylene.
Claim 6
Dependent Claim 23 words
A vaccine delivery system according to claim 1 wherein the container for the water for injection is formed of a vinyl blister pack.
Claim 7
Dependent Claim 20 words
A vaccine delivery system according to claim 1 wherein the container for the water for injection is formed of polypropylene.
Claim 8
Dependent Claim 78 words
In combination, a plurality of single dosage hypodermic syringes each comprising a tubular container portion of plastic material which is resiliently flexible at room temperature and a needle portion comprising a hollow sharp needle extending out from the container portion, a single dosage of a lyophilized vaccine suitable for human administration contained in each tubular container portion and sealed therein, and a gas, moisture and light impervious bag enveloping the plurality of syringes and sealing the syringes therein.
Claim 9
Dependent Claim 78 words
In combination, a plurality of single dosage hypodermic syringes each comprising a tubular container portion of plastic material which is resiliently flexible at room temperature and a needle portion comprising a hollow sharp needle extending out from the container portion, a single dosage of a lyophilized vaccine suitable for human administration contained in each tubular container portion and sealed therein, and a gas, moisture and light impervious bag enveloping the plurality of syringes and sealing the syringes therein.
Claim 10
Dependent Claim 18 words
A combination according to claim 7 wherein the gas, moisture and light impervious bag is of aluminum foil.
Claim 11
Dependent Claim 21 words
A combination according to claim 7 wherein the syringes include removable dust covers enveloping the outer end of their needle portion.
Claim 12
Independent Claim 66 words
A method of preparing vaccine for delivery storage and administration comprising the steps of filling a plurality of single dosage, tubular, flexible, hypodermic syringes with an aqueous vaccine diluted to human administration concentrations, freezing the vaccine, lyophilizing the vaccine, sealing the syringes closed under anhydrous conditions, and enveloping and sealing a plurality of the filled and sealed syringes inside a gas, moisture and light impervious bag.
Claim 13
Independent Claim 66 words
A method of preparing vaccine for delivery storage and administration comprising the steps of filling a plurality of single dosage, tubular, flexible, hypodermic syringes with an aqueous vaccine diluted to human administration concentrations, freezing the vaccine, lyophilizing the vaccine, sealing the syringes closed under anhydrous conditions, and enveloping and sealing a plurality of the filled and sealed syringes inside a gas, moisture and light impervious bag.
Claim 14
Dependent Claim 22 words
A method according to claim 10 further including the step of subjecting the syringe to an ethylene oxide atmosphere prior to filling.
Claim 15
Dependent Claim 24 words
A method according to claim 11 further including the step of subjecting the syringe to a vaccum to purge the syringe of ethylene oxide.

References Cited (Backward Citations)

US2726656A Cited
US2895475A Cited
US3158283A Cited
US3325059A Cited
US3337041A Cited
US3286832A Cited
US3472369A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1980-05-09 1980-11-08 1981-05-10 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1984-05-09 1984-11-08 1985-05-10 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1988-05-09 1988-11-08 1989-05-10 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag